Advancing type 1 diabetes therapy: autologous islet transplant breakthrough

IF 40.8 1区医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

Signal Transduction and Targeted Therapy Pub Date : 2024-12-23 DOI:10.1038/s41392-024-02090-x

Ram Abou Zaki, Assam El-Osta

引用次数: 0

Abstract

The first patient to receive autologous transplantation of chemically induced pluripotent stem-cell-derived islets (CiPSC islets) was recently announced in the journal Cell. The breakthrough surgery by Wang and colleagues at Nankai University, achieved year-long insulin independence for an adult living with type 1 diabetes (T1D).¹

Abstract Image

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Signal Transduction and Targeted Therapy Biochemistry, Genetics and Molecular Biology-Genetics

CiteScore

44.50

自引率

1.50%

发文量

384

审稿时长

5 weeks

期刊介绍： Signal Transduction and Targeted Therapy is an open access journal that focuses on timely publication of cutting-edge discoveries and advancements in basic science and clinical research related to signal transduction and targeted therapy. Scope: The journal covers research on major human diseases, including, but not limited to: Cancer,Cardiovascular diseases,Autoimmune diseases,Nervous system diseases.